Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-02

Clinical Trial Update: The Effect of Dietary Management and Cysteine Supplementation on Growth Parameters and Biochemical Control for Pediatric Qatari Patients Affected with Classical B6 Non-responsive Homocystinuria. [NA]

View source ↗

Summary

This document reports a clinical trial update evaluating dietary management and cysteine supplementation for growth and biochemical control in pediatric patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cysteine supplement (cysteine)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Classical Homocystinuria | NA | Status: NOT_YET_RECRUITING